Zhao X - Search Results

1

Maintenance treatment of Uracil and Tegafur (UFT) in responders following first-line fluorouracil-based chemotherapy in metastatic gastric cancer: a randomized phase II study.

Li W, Zhao X, Wang H, Liu X, Zhao X, Huang M, Qiu L, Zhang W, Chen Z, Guo W, Li J, Zhu X. Li W, et al. Among authors: zhao x. Oncotarget. 2017 Jun 6;8(23):37826-37834. doi: 10.18632/oncotarget.13922. Oncotarget. 2017. PMID: 27980221 Free PMC article. Clinical Trial.

2

[Cytogenetic and interphase FISH studies in the diagnosis of malignant lymphomas].

Hu XC, Bao LM, Zhu XZ, Irons RD, Fu H, Chen Y, Chen H, Zhao XM, Yang XM, Li J. Hu XC, et al. Zhonghua Zhong Liu Za Zhi. 2007 Jan;29(1):45-8. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 17575693 Chinese.

3

Primary non-Hodgkin's lymphoma of the breast: eight-year follow-up experience.

Guo HY, Zhao XM, Li J, Hu XC. Guo HY, et al. Int J Hematol. 2008 Jun;87(5):491-497. doi: 10.1007/s12185-008-0085-4. Epub 2008 Apr 15. Int J Hematol. 2008. PMID: 18414980

4

Biweekly docetaxel-containing chemotherapy may be the optimal schedule.

Yang X, Cai Y, Zhao X, Wang Z, Hong X, Shen Z, Ou Z, Li J, Hu X. Yang X, et al. Among authors: zhao x. Anticancer Drugs. 2008 Apr;19(4):421-6. doi: 10.1097/CAD.0b013e3282f7f52e. Anticancer Drugs. 2008. PMID: 18454052 Clinical Trial.

5

[Prognosis of primary non-Hodgkin's lymphoma of the breast].

Guo HY, Zhao XM, Cao JN, Hu XC, Yin JL, Hong XN, Li J. Guo HY, et al. Zhonghua Zhong Liu Za Zhi. 2008 Mar;30(3):200-2. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 18756936 Chinese.

6

XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects.

Qiu LX, Yao L, Zhang J, Zhu XD, Zhao XM, Xue K, Mao C, Chen B, Zhan P, Yuan H, Hu XC. Qiu LX, et al. Breast Cancer Res Treat. 2010 Nov;124(1):229-35. doi: 10.1007/s10549-010-0813-3. Epub 2010 Mar 5. Breast Cancer Res Treat. 2010. PMID: 20204500

7

The p21 Ser31Arg polymorphism and breast cancer risk: a meta-analysis involving 51,236 subjects.

Qiu LX, Zhang J, Zhu XD, Zheng CL, Sun S, Wang ZH, Zhao XM, Wang JL, Wang LP, Yu H, Xue K, Hu XC. Qiu LX, et al. Breast Cancer Res Treat. 2010 Nov;124(2):475-9. doi: 10.1007/s10549-010-0858-3. Epub 2010 Mar 27. Breast Cancer Res Treat. 2010. PMID: 20349127

8

Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance.

Zhao X, Xu X, Guo L, Ragaz J, Guo H, Wu J, Shao Z, Zhu J, Guo X, Chen J, Zhu B, Wang Z, Hu X. Zhao X, et al. Breast Cancer Res Treat. 2010 Dec;124(3):733-43. doi: 10.1007/s10549-010-1183-6. Epub 2010 Sep 30. Breast Cancer Res Treat. 2010. PMID: 20882405 Clinical Trial.

9

Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies.

Li J, Zhao X, Chen L, Guo H, Lv F, Jia K, Yv K, Wang F, Li C, Qian J, Zheng C, Zuo Y. Li J, et al. Among authors: zhao x. BMC Cancer. 2010 Oct 5;10:529. doi: 10.1186/1471-2407-10-529. BMC Cancer. 2010. PMID: 20923544 Free PMC article. Clinical Trial.

10

Prognostic factors in primary gastric non-Hodgkin's lymphoma--a single-center retrospective analysis of 103 cases from China.

Zhang J, Hu X, Liu X, Wu X, Sun S, Zhang Q, Zhao X, Ren H, Hong X. Zhang J, et al. Among authors: zhao x. Hepatogastroenterology. 2010 Jul-Aug;57(101):989-96. Hepatogastroenterology. 2010. PMID: 21033265

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52,146 results

Search Page

Filters